1JS vs GS71: Side-by-Side Comparison
Compare Shield Therapeutics plc (1JS) and GSK plc (GS71) side by side: market cap EUR 72.73M vs EUR 91.51B. Financials, growth and model signals on Bullrun.
| Metric | 1JS | GS71 |
|---|---|---|
| Company | Shield Therapeutics plc | GSK plc |
| Country / Exchange | United Kingdom · F | United Kingdom · XETRA |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - General |
| Market cap | EUR 72.73M | EUR 91.51B |
| P/E ratio | — | 13.8 |
| Dividend yield | — | 3.40% |
| Valuation model | — | 30.7% undervalued |
| Revenue (FY2025) | EUR 49.70M | GBP 32.67B |
| Revenue growth YoY | +54.4% | +4.1% |
| Net income | EUR -17.66M | GBP 6.29B |
| Gross margin | 46.4% | 72.4% |
| Diluted EPS | -0.02 | 1.39 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.